EXPLORE HOW WE CAN HELP
years in biotech &
life sciences
product & solution
launches supported
CONTINENTS: North america, europe, asia,africa,australia
INDUSTRIES / BIOTECH & LIFE SCIENCES
Your marketing team should understand why.
Complex science, evidence-driven buyers, long validation cycles, and multiple technical and commercial stakeholders require more than generic B2B marketing. Reefline brings real genomics and life-science industry experience to the work.
GENOMICS
DIAGNOSTICS
LAB AUTOMATION
BIOINFORMATICS
RESEARCH TOOLS
biotech startups
lab equipment
WHY BIOTECH IS DIFFERENT
The product may be scientifically strong, but adoption depends on much more than awareness. Buyers need to understand the evidence, application, workflow fit, implementation requirements, and commercial value.
Scientists, lab leaders, procurement teams, distributors, and executives evaluate the same product through different lenses. A credible marketing strategy must connect those perspectives without oversimplifying the science.
That requires a team that understands how the industry works - not an agency learning the fundamentals while your project is already moving.
Scientific accuracy matters. The message must become clearer without becoming technically wrong.
Buying decisions involve scientists, lab leaders, procurement, commercial teams, and executives.
03
Adoption depends on evidence, workflow validation, peer trust, KOLs, and application-specific proof.
04
Product value is rarely in a feature alone - it is in what that feature changes for a real workflow.
05
Sales cycles are shaped by validation, budgets, grants, regulation, and long-term implementation decisions.
06
Marketing must align product, applications, sales, distributors, and leadership around one credible story.
WHERE WE WORK
From emerging platforms to established portfolios, we help technical teams make the market opportunity easier to see and the next step easier to take.
01
Genomics & sequencing
Position platforms, workflows, applications, and services around the scientific and commercial questions buyers actually need answered.
DISCUSS YOUR CHALLENGE
↗
02
Molecular diagnostics
Build clear narratives for complex diagnostic technologies across clinical value, workflow fit, evidence, and adoption.
DISCUSS YOUR CHALLENGE
↗
03
Laboratory equipment & automation
Connect technical specifications to throughput, reliability, usability, cost, and the realities of a working laboratory.
DISCUSS YOUR CHALLENGE
↗
04
Bioinformatics & research tools
Translate software, analytics, and data workflows into practical value for scientists, lab leaders, and commercial teams.
DISCUSS YOUR CHALLENGE
↗
05
Biotech & pharma startups
Clarify how research technologies support discovery, translational work, development, and better scientific decisions.
DISCUSS YOUR CHALLENGE
↗
06
Clinical & research laboratories
Strengthen visibility, differentiation, and lead generation for specialized testing, research, and laboratory services.
DISCUSS YOUR CHALLENGE
↗
FOR EMERGING COMPANIES
Biotech and pharma startups have to build credibility before they have scale.
Early-stage companies are marketing across scientific, financial, and commercial timelines at the same time. The story must be rigorous enough for experts, clear enough for investors and partners, and flexible enough to evolve with the evidence.
Reefline helps scientific founders and lean teams create the strategic foundation of a more mature marketing function - without forcing them into a generic startup playbook.
01
BIOTECH STARTUPS
Turn a strong scientific idea into a market-ready story.
For platform, diagnostics, research-tool, genomics, and laboratory-technology startups, the challenge is often not a lack of innovation. It is making the opportunity, differentiation, application, and commercial path clear before the team has a large marketing function.
Market landscape and priority audience definition
Category, positioning, and value proposition
Scientific-to-commercial messaging
Website, launch, and investor or partner materials
02
PHARMA & THERAPEUTICS STARTUPS
Research, preclinical, and clinical-stage teams need a clear corporate story that connects the unmet need, scientific rationale, program or platform, development stage, and long-term potential for investors, partners, talent, and industry stakeholders.
Corporate and pipeline narrative
Stakeholder-specific message architecture
Website and development-milestone communications
Partner, congress, and ecosystem-facing content
01
Clarify the opportunity
Define the market, audience, unmet need, differentiation, and strongest available proof.
02
Build milestone-ready messaging
Adapt the core story for investors, partners, scientific stakeholders, talent, and future buyers.
03
Prepare for growth
Create the website, content, launch foundation, and roadmap the internal team can build on.
For regulated and pre-approval communications, Reefline works within the company’s review process and alongside its legal, regulatory, and medical experts. Marketing support does not replace regulatory, legal, or medical-affairs review.
INDUSTRY KNOWLEDGE
Reefline’s biotech work is led by a marketer with medical or biotech education, a PhD-level genetics background, and more than a decade of commercial experience across genomics and life-science tools. The Reefline team includes experienced professionals with backgrounds in genomics and life sciences who understand how this industry actually works.
We understand sequencing workflows, molecular methods, assay performance, laboratory automation, bioinformatics, and the evidence technical buyers expect to see.
Our experience connects product, application, marketing, sales, distributor, KOL, and executive teams across international markets - from positioning and launch through portfolio growth.
HOW WE HELP
Start with the market problem. Build the right story. Then give every channel and asset a clear job.
Define the audience, application, category, differentiators, proof points, and commercial story before adding more campaigns.
Market and competitor audit
Audience and buyer mapping
Value proposition
Messaging architecture
Create a connected route from product strategy and scientific evidence to launch assets, channel plans, and sales enablement.
Launch roadmap
Product positioning
Campaign architecture
Sales enablement
Build discoverability and trust through useful technical content, search, paid media, email, landing pages, and conversion paths.
SEO and content
Google and LinkedIn campaigns
Email journeys
Landing pages and analytics
OUR APPROACH
We do not start by choosing channels. We start by understanding what the market needs to believe, what evidence supports it, and what makes action possible.
01
We start with the technology, evidence, workflow, application, and competitive context - not a generic marketing template.
02
We identify who influences the purchase, what each stakeholder needs to understand, and where uncertainty slows action.
03
We connect technical differentiation to a clear, credible value story that works across marketing, product, and sales.
04
We turn the strategy into launches, campaigns, content, enablement, and measurable next steps.
BUSINESS OUTCOMES
Not more marketing activity. More commercial direction.
The goal is to help the right people understand the product, trust the evidence, and move forward with less friction.
Explore all services
A sharper position in a crowded or emerging category
Messaging that works for scientific and commercial audiences
Better alignment across product, marketing, sales, and leadership
Launches built around adoption - not only announcement day
Content and campaigns with a defined role in the buyer journey
A clearer measurement framework for what to improve next
RELEVANT EXPERIENCE
From emerging technologies to established portfolios.
Experience spans product and digital marketing, go-to-market, portfolio development, KOL engagement, distributor enablement, e-commerce, SEO, paid media, content, and sales alignment across global life-science markets.
Contact us
10+
50+
Up to 50%
Global
FAQ
Questions before we go deeper?
A few practical answers about how Reefline works with biotech and life-science teams.
Want to learn more?
What makes biotech and life sciences marketing different from general B2B marketing?
Biotech purchasing decisions often involve scientists, laboratory managers, technical specialists, procurement teams, executives, investors, and strategic partners. Each audience evaluates value differently. Effective biotech marketing must balance scientific accuracy, commercial relevance, credibility, and clear communication across the entire decision-making group.
Does Reefline Marketing have experience in genomics and life sciences?
Yes. Our team includes experienced professionals with backgrounds in genomics, genetics, life-science products, laboratory technologies, and scientific commercialization. This experience helps us understand technical products, scientific customers, industry terminology, and the realities of bringing complex technologies to market.
Does Reefline Marketing have experience in genomics and life sciences?
Yes. Our team includes experienced professionals with backgrounds in genomics, genetics, life-science products, laboratory technologies, and scientific commercialization. This experience helps us understand technical products, scientific customers, industry terminology, and the realities of bringing complex technologies to market.
What types of biotech and life-science companies do you work with?
We support established companies and startups working in genomics, diagnostics, laboratory automation, bioinformatics, research tools, life-science equipment, scientific services, and related areas. We adapt the strategy to the company’s technology, development stage, target audience, commercial goals, and internal resources.
Do you work with biotech startups?
Yes. We help biotech startups establish clear positioning, explain their technology, build market credibility, prepare investor and partner communications, develop their digital presence, and create an early commercialization strategy. Support can evolve as the company moves from validation and fundraising toward partnerships, market entry, and growth.
Do you support pharma and therapeutics startups?
Yes. We support early-stage and growing pharma and therapeutics startups with strategic positioning, pipeline and platform narratives, website content, investor and partner materials, milestone communications, and commercial-readiness planning. Any regulated, clinical, medical, or pre-approval content must be reviewed and approved by the company’s legal, regulatory, and medical teams.
Can you explain complex scientific products to different audiences?
Yes. We help translate complex scientific and technical information into clear messaging for scientists, laboratory leaders, commercial teams, executives, investors, partners, and other relevant audiences. The goal is not to remove the science, but to make its importance, differentiation, and practical value easier to understand.
Can Reefline support a biotech product launch or go-to-market strategy?
Yes. We can support positioning, audience segmentation, competitive analysis, launch messaging, sales and marketing alignment, campaign planning, content development, landing pages, digital advertising, and post-launch optimization. The scope is adapted to the product, market, timeline, and readiness of the internal team.
What biotech marketing services does Reefline provide?
Our services include market and brand audits, positioning and messaging, product marketing, go-to-market strategy, launch and rebrand support, website and landing-page strategy, scientific content, SEO, paid advertising, email marketing, campaign development, and sales-marketing alignment.
Can Reefline support regulated or pre-approval communications?
Reefline can support the strategy, messaging structure, content development, design, and campaign planning surrounding regulated products. However, we do not replace legal, regulatory, clinical, or medical review. Final materials should always be evaluated and approved by the appropriate experts within the client’s organization.